KR930019216A - 종양 치료제 - Google Patents

종양 치료제 Download PDF

Info

Publication number
KR930019216A
KR930019216A KR1019920004389A KR920004389A KR930019216A KR 930019216 A KR930019216 A KR 930019216A KR 1019920004389 A KR1019920004389 A KR 1019920004389A KR 920004389 A KR920004389 A KR 920004389A KR 930019216 A KR930019216 A KR 930019216A
Authority
KR
South Korea
Prior art keywords
tumor treatment
isoguanosine
therapeutic agent
tumor therapeutic
active ingredient
Prior art date
Application number
KR1019920004389A
Other languages
English (en)
Other versions
KR100204309B1 (ko
Inventor
한영복
경홍기
문정조
김춘원
김종배
김정한
Original Assignee
김영길
주식회사 녹십자
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김영길, 주식회사 녹십자 filed Critical 김영길
Priority to KR1019920004389A priority Critical patent/KR100204309B1/ko
Publication of KR930019216A publication Critical patent/KR930019216A/ko
Application granted granted Critical
Publication of KR100204309B1 publication Critical patent/KR100204309B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 이소구아노신을 유효성분으로 함유하는 종양 치료제에 관한 것이다.

Description

종양 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 이소구아노신의 종양 치료효과에 대한 유효용량 스펙트럼을 나타내다.

Claims (2)

  1. 이소구아노신을 유효성분으로 함유하는 종양 치료제.
  2. 제1항에 있어서, 이소구아노신과 약학적 불활성 성분을 함유하는 종양치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019920004389A 1992-03-18 1992-03-18 종양 치료제 KR100204309B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920004389A KR100204309B1 (ko) 1992-03-18 1992-03-18 종양 치료제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920004389A KR100204309B1 (ko) 1992-03-18 1992-03-18 종양 치료제

Publications (2)

Publication Number Publication Date
KR930019216A true KR930019216A (ko) 1993-10-18
KR100204309B1 KR100204309B1 (ko) 1999-06-15

Family

ID=19330509

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920004389A KR100204309B1 (ko) 1992-03-18 1992-03-18 종양 치료제

Country Status (1)

Country Link
KR (1) KR100204309B1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108659078A (zh) * 2017-04-01 2018-10-16 南京泽朗生物科技有限公司 一种巴豆苷的提取方法
CN110151776A (zh) * 2019-04-25 2019-08-23 四川大学 一种双功能核苷水凝胶及其制备方法和用途

Also Published As

Publication number Publication date
KR100204309B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
KR870005637A (ko) 약물 데포
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
GEP20002332B (en) Cefalosporin Derivatives
ATE15596T1 (de) Pharmazeutische mittel.
KR890015742A (ko) 이병치료용 국소 제제
RU94044438A (ru) Применение 2-фенил-3-ароилбензтиофенов для подавления способности к зачатию у женщин
KR930019216A (ko) 종양 치료제
DE69314463D1 (de) Hautregenerierende kosmetische zusammensetzung
DE69532819D1 (de) Kohlenhydrate derivate und die enthaltende zusammensetzungen
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
CA2136140A1 (en) Carcinostatic for hormonotherapy containing dienogest as effective component
KR890001540A (ko) 심부전증 치료제
KR950007852A (ko) 우라실을 유효성분으로 함유하는 관절염 치료제
DE69114922D1 (de) Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten.
KR940011006A (ko) 황금추출물을 유효성분으로 하는 치주질환예방 및 치료제 조성물
KR930019217A (ko) 종양 치료제
KR930007451A (ko) 우리딘을 유효성분으로 함유하는 관절염 치료제
ATE74505T1 (de) Schmerzpraeparat.
KR900017599A (ko) 종양 치료용 약학 조성물
KR920700641A (ko) 클로르메티아졸의 신경 변성 예방 및(또는) 치료용 용도
KR910021244A (ko) 당뇨병성 괴저 치료제
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
UA30143C2 (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050325

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee